Surgery Partners Aktie

Surgery Partners für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A14YWP / ISIN: US86881A1007

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
06.08.2025 07:09:09

Surgery Partners (SGRY) Q2 Revenue Up 8%

Surgery Partners (NASDAQ:SGRY), a leading operator of ambulatory surgical facilities, announced its results for the second quarter on August 5, 2025. The company reported GAAP revenue of $826.2 million, surpassing analyst GAAP estimates of $818.4 million, while Non-GAAP earnings per share (EPS) came in at $0.17, slightly missing the $0.18 consensus (non-GAAP). Adjusted EBITDA grew 9.0% year-over-year as Surgery Partners reaffirmed its full-year 2025 guidance. Despite continued top-line expansion and improved EBITDA, ongoing net losses and higher costs tied to network growth weighed on the bottom line, making it an eventful quarter with a mixed financial picture. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Surgery Partners operates a nationwide network of over 160 ambulatory surgery centers (ASCs) and surgical hospitals, providing facilities where surgeons perform same-day, minimally invasive procedures. Its business is built on serving patients, physicians, and payors seeking alternatives to traditional hospital surgery through efficient, cost-effective, and high-quality outpatient settings.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Surgery Partners Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Q2 Holdings Inc 57,00 0,88% Q2 Holdings Inc
Surgery Partners Inc 18,10 1,69% Surgery Partners Inc